Inventor · disambiguated record
Chang Ki Lim
Also filed as: LIM CHANG K · LIM CHANG KI
16 granted patents·12 pending applications·200 citations·filing 2003–2022
93Inventor score
Top patents by PatentIndex Score
28 records- 0198US10370426B2Triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2018·Granted Aug 6, 2019·21 cites·16 claims
- 0297US8124094B2Immunoglobulin Fc fragment modified by non-peptide polymer and pharmaceutical composition comprising the sameKIM YOUNG MIN·Filed 2005·Granted Feb 28, 2012·63 cites·13 claims
- 0396US7737260B2Protein complex using an immunoglobulin fragment and method for the preparation thereofHANMI PHARM IND CO LTD·Filed 2004·Granted Jun 15, 2010·54 cites·45 claims
- 0493US10400020B2Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2018·Granted Sep 3, 2019·10 cites·24 claims
- 0593US8163889B2Physiologically active polypeptide conjugate having prolonged in vivo half-lifeKIM YOUNG-MIN·Filed 2009·Granted Apr 24, 2012·14 cites·17 claims
- 0690US11332508B2Triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2019·Granted May 17, 2022·2 cites·34 claims
- 0790US8476230B2Insulinotropic complex using an immunoglobulin fragmentSONG DAE HAE·Filed 2008·Granted Jul 2, 2013·18 cites·20 claims
- 0886US10981967B2Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonistHANMI PHARM IND CO LTD·Filed 2019·Granted Apr 20, 2021·3 cites·41 claims
- 0985US9422349B2N-terminal modified exendin-4JUNG SUNG YOUB·Filed 2008·Granted Aug 23, 2016·8 cites·8 claims
- 1080US2022213164A1Triple glucagon/glp-1/gip receptor agonistHANMI PHARM IND CO LTD·Filed 2022·Application pending·0 cites
- 1178US12018060B2Glucagon derivativesHANMI PHARMACEUTICAL CO LTD·Filed 2021·Granted Jun 25, 2024·0 cites·10 claims
- 1277US10071166B2Protein complex using an immunoglobulin fragment and method for the preparation thereofHANMI SCIENCE CO LTD·Filed 2013·Granted Sep 11, 2018·1 cites·16 claims
- 1375US10253082B2Long-acting insulin and use thereofHANMI PHARM IND CO LTD·Filed 2015·Granted Apr 9, 2019·2 cites·18 claims
- 1475US2021188937A1Long-acting conjugate of triple glucagon/glp-1/gip receptor agonistHANMI PHARM IND CO LTD·Filed 2021·Application pending·0 cites
- 1574US11254724B2Glucagon derivativesHANMI PHARM IND CO LTD·Filed 2019·Granted Feb 22, 2022·0 cites·10 claims
- 1671US8829163B2Liquid formulations for long-acting erythropoietin conjugateBAE SUNG MIN·Filed 2011·Granted Sep 9, 2014·3 cites·17 claims
- 1770US2018326083A1Protein complex using an immunoglobulin fragment and method for the preparation thereofHANMI SCIENCE CO LTD·Filed 2018·Application pending·0 cites
- 1867US10251957B2Composition for treating diabetes comprising long-acting insulin conjugate and long-acting insulinotropic peptide conjugateWOO YOUNG EUN·Filed 2012·Granted Apr 9, 2019·1 cites·15 claims
- 1966US2008124347A1Insulinotropic peptide conjugate using carrier substanceHANMI PHARM IND CO LTD·Filed 2007·Application pending·0 cites
- 2066US2008085862A1Natriuretic peptide conjugate using carrier substanceHANMI PHARM IND CO LTD·Filed 2007·Application pending·0 cites
- 2159US2005176108A1Physiologically active polypeptide conjugate having prolonged in vivo half-lifeFiled 2003·Application pending·0 cites
- 2259US2010255014A1Protein Complex Using An Immunoglobulin Fragment and Method For The Preparation ThereofHANMI PHARM IND CO LTD·Filed 2010·Application pending·0 cites
- 2358US10513550B2Glucagon derivativesHANMI PHARM IND CO LTD·Filed 2015·Granted Dec 24, 2019·0 cites·10 claims
- 2456US2024254220A1Combined therapy using anti-cd300c antibodyCENTRICSBIO INC·Filed 2022·Application pending·0 cites
- 2554US2004180054A1Physiologically active polypeptide conjugate having prolonged in vivo half-lifeHANMI PHARM IND CO LTD·Filed 2004·Application pending·0 cites
- 2653US2006276586A1Peg-physiologically active polypeptide homodimer complex having prolonged in vivo half-life and process for the preparation thereofHANMI PHARM IND CO LTD·Filed 2004·Application pending·0 cites
- 2751US2019083579A1Composition for treating diabetes comprising long-acting insulin conjugate and long-acting insulinotropic peptide conjugateHANMI SCIENCE CO LTD·Filed 2018·Application pending·0 cites
- 2848US2009238838A1Insulinotropic peptide conjugate using an immunoglobulin fcHANMI PHARM IND CO LTD·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chang Ki Lim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →